1. Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
   Yanyan Wang et al, 2020, Frontiers in Genetics CrossRef
2. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells
   Krishnapriya M. Varier et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
3. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
   Jixin Wang et al, 2021, Frontiers in Genetics CrossRef
4. Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression
   Butong Sun et al, 2021, Open Medicine CrossRef
5. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer
   Weiqi Nian et al, 2022, Combinatorial Chemistry & High Throughput Screening CrossRef
6. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness via regulating the miR-587/bone morphogenetic protein 3 axis in lung adenocarcinoma
   Hongfei Guo et al, 2022, Human & Experimental Toxicology CrossRef
7. LINC00667 Sponges miR-4319 to Promote the Development of Nasopharyngeal Carcinoma by Increasing FOXQ1 Expression
   Bing Liao et al, 2021, Frontiers in Oncology CrossRef
8. LncRNAs in Non-Small-Cell Lung Cancer
   Lucy Ginn et al, 2020, Non-Coding RNA CrossRef
9. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma
   Junfan Pan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef